l.pires
TL2 Moderator · Aarhus
Contributes reviews on supplier material. Based in Aarhus.
Joined 19 February 2025 · last posted 3d · groups: regional-na
83Posts here
4Topics
1Solutions
1.1kLikes received
1.7kLikes given
26Badges
230Days visited
5.2kPosts read
Recent activity
Full stream-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #95 · Practice › Dosing & titration · 25 Jul 2026 · 4 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #13 · Compounds › Tirzepatide · 21 Jul 2026 · 0 likes This follows post #10 rather than contradicting it. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent…
-
Which categories are strict and which are relaxed, honestly Replied, post #24 · Start Here › Welcome · 17 Jul 2026 · 2 likes Picking up post #21: that is the part I would want checked first. The moderation log is public. Every staff action is logged with the rule cited and the reasoning…
-
Common supplements people ask about, assessed one at a time Replied, post #56 · Practice › Interactions · 16 Jul 2026 · 25 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Blinding yourself: practical methods and their limits — the long version Replied, post #10 · Research Methods › N-of-1 designs · 16 Jul 2026 · 18 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #32 · Access › Insurance & coverage · 15 Jul 2026 · 3 likes post #31 answers the question as asked. The question underneath it is different. Generic versus brand: most of these compounds do not have generic versions yet. Once…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #82 · Analytics › Home & field testing · 13 Jul 2026 · 0 likes This follows post #79 rather than contradicting it. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #15 · Practice › Interactions · 11 Jul 2026 · 8 likes post #14 answers the question as asked. The question underneath it is different. Food interactions: most interactions are absorption interactions. Some medications…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #38 · Evidence › Journal club · 8 Jul 2026 · 15 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
A structured critique template this community uses — a second dataset Replied, post #30 · Evidence › Study critique · 6 Jul 2026 · 4 likes On post #26 — agreed on the reasoning, with one qualification. Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not…
-
Tracking a shortage from primary sources rather than rumour Replied, post #84 · Access › Shortages · 4 Jul 2026 · 9 likes This follows post #81 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Alcohol: what is documented and what is folklore Replied, post #84 · Practice › Interactions · 30 Jun 2026 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…